Seref Rahmi Yilmaz
Overview
Explore the profile of Seref Rahmi Yilmaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balan K, Akdogan N, Haberal G, Yilmaz S
Australas J Dermatol
. 2025 Feb;
PMID: 39985234
No abstract available.
2.
Haberal G, Saglam A, Yildirim T, Yilmaz S, Yeter H
CEN Case Rep
. 2024 Jul;
PMID: 39060835
Kidney transplant recipients are at an increased risk of various infections due to immunosuppressive medications. Among them, fungal infections are associated with high mortality and morbidity. This report presents the...
3.
Ozbek D, Koc S, Ozkan N, Erdogan Kablan S, Yet I, Uner M, et al.
J Proteomics
. 2023 Dec;
293:105064.
PMID: 38154551
Urinary omics has become a powerful tool for elucidating pathophysiology of glomerular diseases. However, no urinary omics analysis has been performed yet on renal AA amyloidosis. Here, we performed a...
4.
Haberal G, Yildirim T, Yilmaz S, Altun B, Aki F, Erdem Y, et al.
Nephron
. 2023 Oct;
148(3):171-178.
PMID: 37788664
Background: Living kidney donors (LKD) may experience some untoward consequences following donation such as development of chronic kidney disease (CKD). In this study, we aimed to investigate the rate of...
5.
Yildirim T, Gok-Oguz E, Koc N, Uzerk-Kibar M, Uner M, Saglam E, et al.
Nephron
. 2021 Dec;
146(2):172-178.
PMID: 34852341
Introduction: Patients with AA amyloidosis may present with acute kidney injury that progresses to end-stage kidney disease in a short period of time. Acute allergic tubulointerstitial nephritis (aTIN) is a...
6.
Yildirim T, Kutahya B, Is F, Erdevir M, Kibar M, Koc N, et al.
Turk J Med Sci
. 2021 May;
51(5):2364-2368.
PMID: 33984890
Background/aim: Compared to healthy controls, mean platelet volume (MPV) is frequently higher in patients with Familial Mediterranean fever (FMF) but lower in AA amyloidosis patients. The reason for the difference...
7.
Kurtaran M, Koc N, Aksun M, Yildirim T, Yilmaz S, Erdem Y
Ther Adv Drug Saf
. 2021 May;
12:20420986211009358.
PMID: 33953901
Plain Language Summary: Sirolimus is a drug that suppresses the immune response used to prevent organ rejection in people who have had kidney transplants. In order to reach the optimum...
8.
Yazirli B, Kara E, Inkaya A, Maden S, Ozberk U, Yildirim T, et al.
Transpl Infect Dis
. 2021 Mar;
23(4):e13593.
PMID: 33655683
Tigecycline has been approved by the US (United States) Food and Drug Administration in a variety of complicated infections due to its broad-spectrum antibiotic activity. Following phase III trials, the...
9.
Koc N, Yilmaz S, Karcaaltincaba M, Yildirim T, Erdem Y
Iran J Kidney Dis
. 2021 Jan;
1(1):61-63.
PMID: 33492306
Renal lymphangiomatosis is an unusual disorder. It may develop due to the abnormality of the intrarenal, peripelvic and perirenal lymphatics. The differential diagnosis contains renal lymphoma, polycystic kidney disease, multicystic...
10.
Tecen-Yucel K, Bayraktar-Ekincioglu A, Yildirim T, Yilmaz S, Demirkan K, Erdem Y
J Manag Care Spec Pharm
. 2020 Sep;
26(10):1291-1296.
PMID: 32996393
Background: Potential drug-drug interactions (pDDIs) with immunosuppressive drugs are frequently observed in renal transplant recipients. Drug interaction programs are acknowledged as a fundamental tool to alert physicians to pDDIs, but...